Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Evaluation of the efficacy and safety of a 3-weekly TS-1 regimen as adjuvant therapy for stage II and III advanced gastric cancer: A pilot study.
Authors
Jihong Bae
Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea
Jihong Bae , Sun Jin Sym , Joo-Hwan Park , Young Saing Kim , Hee Kyung Ahn , EUN KYUNG CHO , Dong Bok Shin , Ji-Hyeon Park , Jun-Young Yang , Woon-Kee Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 350)
DOI
10.1200/JCO.2024.42.3_suppl.350
Abstract #
350
Poster Bd #
G11
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Short- and long-term outcomes following laparoscopic gastrectomy for advanced gastric cancer compared with open gastrectomy.
First Author: Kazuaki Shibuya
Poster
2017 Gastrointestinal Cancers Symposium
Tumor infiltrative pattern predicts sites of recurrence after curative gastrectomy for gastric cancer .
First Author: Mitsuro Kanda
Poster
2016 Gastrointestinal Cancers Symposium
Body mass index to predict the long-term outcomes of advanced gastric cancer.
First Author: Jae Gyu Kim
Poster
2015 ASCO Annual Meeting
Time-dependent patterns of recurrence and death in resected colon cancer (CC): Pooled analysis of 12,223 patients from modern trials in the ACCENT database containing oxaliplatin.
First Author: Lindsay A. Renfro